Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

In vivo CRISPR screen targeting TSGs in 185-3 MPNST cells

ABSTRACT: In vivo CRISPR screen targeting TSGs in 185-3 MPNST cells

PROVIDER: PRJEB46368 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	ERR6296380.fastq.gz	Fastqsanger.gz
	ERR6296390.fastq.gz	Fastqsanger.gz
	ERR6296400.fastq.gz	Fastqsanger.gz
	ERR6296410.fastq.gz	Fastqsanger.gz
	ERR6296420.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 136

Similar Datasets

In vivo CRISPR screen targeting TSGs in 185-3 MPNST cells

Project description:185-3 MPNST cells cells were screened with a CRISPR library against TSGs in vitro and as tumors in Rag1-null and immunocompetent WT C57BL/6 mice

2021-10-01 | E-MTAB-10729 | biostudies-arrayexpress

In vivo CRISPR screen targeting TSGs in B16 melanoma cells

Project description:B16 melanoma cells were screened with a CRISPR library against TSGs in vitro and as tumors in Rag1-null and immunocompetent WT C57BL/6 mice

2021-10-01 | E-MTAB-10728 | biostudies-arrayexpress

In vivo CRISPR screen targeting TSGs in B16 melanoma cells

Project description:In vivo CRISPR screen targeting TSGs in B16 melanoma cells

| PRJEB46369 | ENA

In vivo CRISPR screen targeting TSGs in KP1233 lung tumor cells

Project description:KP1233 lung tumor cells cells were screened with a CRISPR library against TSGs in vitro and as tumors in Rag1-null and immunocompetent WT C57BL/6 mice

2021-10-01 | E-MTAB-10725 | biostudies-arrayexpress

In vivo CRISPR screen targeting TSGs in KP1233 lung tumor cells

Project description:In vivo CRISPR screen targeting TSGs in KP1233 lung tumor cells

| PRJEB46339 | ENA

In vivo oncogenomics screen identifies novel ependymoma oncogenes and tumor suppressor genes within large chromosomal alterations

Project description:Cancers are characterized by non-random, chromosome copy number variations that presumably contain oncogenes and tumor suppressor genes (TSGs). The affected loci are often large, making it difficult to pinpoint which genes are driving the cancer. Here, we report a cross-species, in vivo screen of 84 candidate oncogenes and 39 candidate TSGs, located within 28 recurrent chromosomal alterations in ependymoma. Through a series of mouse models we validate eight new ependymoma oncogenes and 11 TSGs that dysregulate a small number of cell functions including vesicle trafficking and cholesterol biosynthesis; pinpointing these as potential points for therapeutic intervention. Mouse cortical tumors were excised. These tumors derived from cells expressing one of 3 genes: RAB3A, BC74C, or ZNF668

2015-04-28 | E-GEOD-67497 | biostudies-arrayexpress

Mouse pancreas cell CRISPR screen targeting TSGs for total HLA and SIINFEKL presentation plus/minus interferon gamma

Project description:C57BL/6 mouse pancreas cells were infected with a CRISPR library targeting TSGs. Total HLA and SIINFEKL presentation was measured by flow and cells were sorted for sequencing

2021-10-01 | E-MTAB-10723 | biostudies-arrayexpress

In vivo oncogenomics screen identifies novel ependymoma oncogenes and tumor suppressor genes within large chromosomal alterations

2015-04-28 | GSE67497 | GEO

Mortierella sp. AD 185 isolate:AD 185

Project description:Mortierella sp. AD 185 Transcriptome - AD 185

| PRJNA582288 | ENA

Genomic characterization of the MPNST

Project description:Malignant peripheral nerve sheath tumor (MPNST) is a rare sarcoma that lacks effective therapeutic strategies. By characterizing recurrent gene copy number aberrations, we gain insight into the most altered pathways with the purpose of scanning possible therapeutic targets. We conducted a microarray-based comparative genomic hybridization profiling of two cohorts of primary MPNST tissue samples including 25 patients treated at The University of Texas MD Anderson Cancer Center and 26 patients from Tianjin Cancer Hospital. All samples had at least 90% tumor content. Commercially available normal genomic DNAs were used as control.

2011-11-26 | E-GEOD-33881 | biostudies-arrayexpress

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data